Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib)Pulsed field ablation – or PFA – is a minimally invasive procedure that uses high-energy electrical pulses…

Abbott receives FDA approval for Volt PFA system

Abbott can now compete with Medtronic, Boston Scientific and J&J in the U.S. for the fast-growing pulsed field ablation market.

FDA approves Abbott’s Volt PFA system for atrial fibrillation

The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for patients with atrial fibrillation (AFib).The post FDA approves Abbott’s Volt PFA system for atrial fibrillation appeared first on Medical Device Network.